They demonstrated that a single administration of AAV1 co-expressing insulin and glucokinase in skeletal cells could maintain dogs (n = 6) with diabetes in a normoglycemic state for over 8 years without hypoglycemic episodes (HbA1c ≤ 6.5%), while also preventing secondary complications [38,39]. This evidence concerns the gene GCK and diabetes mellitus.